Nordson Corporation
NASDAQ: NDSN
Stock price
333.58 USD
(+0%) TODAY
Financial Performance
5Y price score: 60
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 252.1%
US$ Per
Share
By default your notes are visible only to you.
220.0
52-week range
338.5
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
3.9 %
Dividend Yield TTM
1 %
Market cap $
$ 18,586
Price / Earnings TTM
33.7
Price / Book TTM
5.7
PEG TTM
1.4
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
49.1 %
48.2 %
252.1 %
Free cash flow per share growth
6.5 %
50.3 %
255.4 %
Earnings per share growth
23.5 %
99.3 %
146.7 %
Business Summary:
Latest Earnings Call Takeaways
2026 Q3 (Aug 20, 2026)
1) Strong Financial Performance
- Record sales of $818 million in Q3 2026, a 10% increase YoY, with 12% organic growth across all segments.
- Adjusted earnings per share reached $3.25, up 19% from the previous year.
- EBITDA of $262 million, representing 32% of sales, also a record for the company.
- Free cash flow of $237 million, with a conversion rate exceeding 100% of net income.
2) Segment Highlights
- Industrial Precision Solutions (IPS): Sales of $367 million, a 5% increase YoY, with organic growth of 3%. EBITDA margin held steady at 35%.
- Medical and Fluid Solutions (MFS): Achieved record sales of $231 million, with 11% organic growth. EBITDA margin improved to 38%.
- Advanced Technology Solutions (ATS): Sales reached $220 million, a 28% increase YoY, with 31% organic growth and an EBITDA margin of 30%.
3) Strategic Execution and Market Position
- The Ascend Strategy continues to drive growth, leveraging competitive advantages in differentiated products and customer relationships.
- Backlog increased by 35% YoY, indicating strong future demand and order entry momentum.
- The company is focused on maintaining high margins while pursuing growth opportunities in semiconductor and medical markets.
4) Challenges and Operational Focus
- The company is managing inflationary pressures and geopolitical factors impacting costs.
- IPS margins are stable but down YoY, reflecting a balance between growth and margin maintenance.
- Ongoing investments in innovation and operational excellence are aimed at enhancing productivity and profitability.
5) Guidance and Outlook
- Full-year sales guidance increased to $3.035 billion to $3.075 billion, with adjusted earnings expected between $11.80 and $12 per share.
- The company anticipates continued strong performance into FY 2027, particularly in ATS and MFS segments.
- M&A remains a strategic focus, with a healthy pipeline and disciplined criteria for acquisitions.
Bottom line: Nordson Corporation is demonstrating robust financial growth and operational strength, positioning itself well for continued success in the coming quarters, driven by strategic execution and a strong backlog. Shareholders can expect sustained value creation through disciplined growth and capital allocation strategies.
Annual Reports, Presentations And IR Contacts
Go to the websiteNordson Corporation — Financial Overview, Stock Price, Market Cap
Nordson Corporation is a company. Founded in 1935. As of August 26, 2026, the company's market capitalization is $18586410440 with a current stock price of $333.58.
